Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
1. ColoAlert receives MHRA registration for UK marketing. 2. ColoAlert targets colorectal cancer detection, complementing existing screening programs. 3. CEO emphasizes goal to increase preventive screening participation. 4. UK colorectal cancer cases number approximately 44,000 annually. 5. ColoAlert offers a non-invasive stool sample test for patients.